Phase 1 study of the pharmacokinetics and clinical proof-of-concept activity of a biofilm-disrupting human monoclonal antibody in patients with chronic prosthetic joint infection of the knee or hip.

Saved in:
Bibliographic Details
Title: Phase 1 study of the pharmacokinetics and clinical proof-of-concept activity of a biofilm-disrupting human monoclonal antibody in patients with chronic prosthetic joint infection of the knee or hip.
Authors: Conway J; Rubin Institute for Advanced Orthopedics, Sinai Hospital of Baltimore, LifeBridge Health, Baltimore, Maryland., Delanois RE; Rubin Institute for Advanced Orthopedics, Sinai Hospital of Baltimore, LifeBridge Health, Baltimore, Maryland., Mont MA; Rubin Institute for Advanced Orthopedics, Sinai Hospital of Baltimore, LifeBridge Health, Baltimore, Maryland., Stavrakis A; University of California Los Angeles, Los Angeles, California, USA., McPherson E; University of California Los Angeles, Los Angeles, California, USA., Stolarski E; Gulfcoast Research Institute, Sarasota, Florida, USA., Incavo S; Houston Methodist Hospital, Houston, Texas, USA., Oakes D; University of Southern California, Los Angeles, California, USA., Salvagno R; Meritus Medical Center, Hagerstown, Maryland, USA., Adams JS; University of California Los Angeles, Los Angeles, California, USA., Kisch-Hancock A; Trellis Bioscience, Inc., Redwood City, California, USA., Tenorio E; Trellis Bioscience, Inc., Redwood City, California, USA., Leighton A; Trellis Bioscience, Inc., Redwood City, California, USA., Ryser S; Trellis Bioscience, Inc., Redwood City, California, USA., Kauvar LM; Trellis Bioscience, Inc., Redwood City, California, USA., Bernthal NM; University of California Los Angeles, Los Angeles, California, USA.
Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2024 Aug 07; Vol. 68 (8), pp. e0065524. Date of Electronic Publication: 2024 Jul 16.
Publication Type: Journal Article; Clinical Trial, Phase I; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1098-6596
DOI:10.1128/aac.00655-24